Cahira Technologies
World’s First Autonomous, Non-surgical Electronic Implant For Seamless Brain Computer Symbiosis
Idea in Biotechnology
Introduction
Cahira Technologies Inc is an MIT spinoff company, and we have built the world’s first autonomous and non-surgical electronic implant for treating intractable neural diseases and for human augmentation. Our multiple award-winning technology involves sub-cellular sized wireless electronic devices that can seamlessly integrate with the brain enabling brain-computer symbiosis beyond conventional brain-computer interfaces.
Moreover, while current brain implants require invasive surgery and are limited to about 1% of the patients, our technology completely defies the need for surgery, eliminating surgery related costs & risks. Furthermore, it enables autonomous recognition of the diseased targets to access brain regions otherwise inaccessible. By eliminating surgery, we are making our life-changing treatment accessible to all, removing barriers of age, health status, and cost that currently prevent millions from receiving treatment. Beyond treating diseases, with our unique brain-computer symbiosis we envision trascending humans beyond biological limitations.
Problem
Every year, millions of patients suffering from devastating neurological conditions face an impossible choice: undergo risky brain surgery, or continue living with debilitating symptoms that drugs can't fix.
Opportunity
Autonomous, non-surgical electronic brain implants. Our nanoelectronic-devices can be introduced into the body without surgery and can autonomously implant in target brain regions to enable highly precise treatment. Tech is already de-risked in pre-clinical animal studies. This technology has won multiple awards.
According to the World Health Organization, over 3 billion people suffer from neural disorders. However, today's surgical brain implants help <1% of patients due to their invasiveness, risks, and costs. Our technology solves these challenges and envisions democratizing neural implants to help people worldwide suffering from debilitating neurological conditions, which drugs cannot treat as well as to augment humans.